BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

25 related articles for article (PubMed ID: 37634439)

  • 1. Survival among women diagnosed with screen-detected or interval breast cancer classified as true, minimal signs, or missed through an informed radiological review.
    Tsuruda KM; Hovda T; Bhargava S; Veierød MB; Hofvind S
    Eur Radiol; 2021 May; 31(5):2677-2686. PubMed ID: 33180162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mammographic features and risk of breast cancer death among women with invasive screen-detected cancer in BreastScreen Norway 1996-2020.
    Moshina N; Backmann HA; Skaane P; Hofvind S
    Eur Radiol; 2024 May; 34(5):3364-3374. PubMed ID: 37935848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparisons of assessment pathways after abnormal mammography screening in Denmark, Norway, and Spain.
    Jørgensen SF; Sagstad S; Louro J; Román M; Castells X; Hofvind S; Njor S
    Breast Cancer Res Treat; 2024 May; 205(1):135-145. PubMed ID: 38285110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Association Between Mammography Screening Frequency and Breast Cancer Treatment and Outcomes: A Retrospective Cohort Study.
    Liu Y; Gordon AS; Eleff M; Barron JJ; Chi WC
    J Breast Imaging; 2023 Feb; 5(1):21-29. PubMed ID: 38416960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fatal and non-fatal breast cancers in women targeted by BreastScreen Norway: a cohort study.
    Tsuruda KM; Hoff SR; Akslen LA; Hofvind S
    Br J Cancer; 2024 Jan; 130(1):99-107. PubMed ID: 38049556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using semi-Markov processes to study timeliness and tests used in the diagnostic evaluation of suspected breast cancer.
    Hubbard RA; Lange J; Zhang Y; Salim BA; Stroud JR; Inoue LY
    Stat Med; 2016 Nov; 35(27):4980-4993. PubMed ID: 27439856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between Delayed Breast Cancer Diagnosis and Behavioral Economic Factors and Personality Characteristics.
    Shinden Y; Kamimura K; Hayashi N; Nomoto Y; Nagata A; Eguchi Y; Yano H; Saho H; Nakajo A; Minami K; Hirashima T; Sasaki K; Yoshinaka H; Owaki T; Tanimoto A; Nakamura M; Otsuka T
    Asian Pac J Cancer Prev; 2023 Oct; 24(10):3437-3440. PubMed ID: 37898848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Distinction Between Interval and Missed Breast Cancer Requires Re-evaluation of Prior Imaging.
    Şendur HN; Şendur AB
    Acad Radiol; 2023 Dec; 30(12):3166. PubMed ID: 37858504
    [No Abstract]   [Full Text] [Related]  

  • 9. Delay in Diagnosis and Treatment of Breast Cancer among Women Attending a Reference Service in Brazil.
    Romeiro Lopes TC; Gravena AAF; Demitto MO; Borghesan DHP; Dell`Agnolo CM; Brischiliari SCR; Carvalho MDB; Pelloso SM
    Asian Pac J Cancer Prev; 2017 Nov; 18(11):3017-3023. PubMed ID: 29172274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of the transition from screen-film to digital screening mammography on interval cancer characteristics and treatment - a population based study from the Netherlands.
    Nederend J; Duijm LE; Louwman MW; Coebergh JW; Roumen RM; Lohle PN; Roukema JA; Rutten MJ; van Steenbergen LN; Ernst MF; Jansen FH; Plaisier ML; Hooijen MJ; Voogd AC
    Eur J Cancer; 2014 Jan; 50(1):31-9. PubMed ID: 24275518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of full field digital mammography on the classification and mammographic characteristics of interval breast cancers.
    Knox M; O'Brien A; Szabó E; Smith CS; Fenlon HM; McNicholas MM; Flanagan FL
    Eur J Radiol; 2015 Jun; 84(6):1056-61. PubMed ID: 25816990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Causes and consequences of delayed diagnosis in breast cancer screening with a focus on mammographic features and tumour characteristics.
    van der Veer EL; Lameijer J; Coolen AMP; Bluekens AMJ; Nederend J; Gielens M; Voogd A; Duijm L
    Eur J Radiol; 2023 Oct; 167():111048. PubMed ID: 37634439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of nonparticipation at previous screening rounds on the characteristics of screen-detected breast cancers.
    Duijm LEM; Broeders MJM; Setz-Pels W; van Breest Smallenburg V; van Beek HC; Donkers-van Rossum AB; Slob MJ; Kuipers TP; Mann RM; Voogd AC
    Eur J Radiol; 2022 Sep; 154():110391. PubMed ID: 35679699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delayed diagnosis of breast cancer in women recalled for suspicious screening mammography.
    Duijm LE; Groenewoud JH; de Koning HJ; Coebergh JW; van Beek M; Hooijen MJ; van de Poll-Franse LV
    Eur J Cancer; 2009 Mar; 45(5):774-81. PubMed ID: 19046632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumour characteristics of bilateral screen-detected cancers and bilateral interval cancers in women participating at biennial screening mammography.
    van Bommel R; Lameijer JRC; Voogd AC; Nederend J; Louwman MWJ; Setz-Pels W; Strobbe LJ; Tjan-Heijnen VCG; Duijm LE
    Eur J Radiol; 2018 Nov; 108():215-221. PubMed ID: 30396659
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.